- Implement a proteomic platform focused on clinical applications
- Discovery of biomarkers for diagnosis, prognosis of diseases and monitor drug response
- The platform is built on state-of-the-art mass spectrometry technology
ACTIVITIES
- Develop methodologies for systematic quantitative proteomics
- Discovery of protein biomarkers associated with cancers (e.g. lung, bladder) and infectious diseases
- Implement a mass spectrometry-based platform for clinical proteomics studies, leveraging the SRM technique
- The LCP will closely collaborate with University of Luxembourg in research and education activities.